MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
RGEN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Repligen (RGEN) Ownership - Who owns Repligen?

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
41 Seyon Street
Phone
+1 781 250-0111
Employees
2000
Web
https://www.repligen.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
9.79B
P/E Ratio
234.45
Total Cash
810.45M
Projected Growth
1.94
Total Debt
690.94M
Revenue
785.1M
Risk (Beta)
1.23
Dividend Yield
N/A
Total Cash/Share
14.36
Total Debt/Equity
N/A
Revenue/Share
13.86 USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
RGEN
Alerts
Alerts
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI Trading Bots for RGEN
Related Blogs
NEPH

Nephros (NEPH) Delivers 18% Revenue Growth in Q3 Despite Margin Headwinds

PDEX

Pro-Dex (PDEX): Is the $80 Level Within Reach?

POCI

Precision Optics Corporation (POCI): Transitioning Through Fiscal 2027 with Satellite and Medical Growth Ahead

HBIO

Harvard Bioscience (HBIO) Q3 Earnings: Revenue Rises 8% With Mixed Margin Signals

TFX

Teleflex (TFX) Delivers +39.2% Adjusted EPS Growth in Q3 Amid Portfolio Shift

View all blogs related to
#PharmaceuticalsOther
Interesting Articles

What Rights Does Owning Shares of Corporation Give You?

What is ChatGPT and How Does It Work?

What are Accounting Policies?

Best Bank Stocks to Buy: Navigating the Financial Titans

Are Bullish Divergences and Bearish Reversal Signals Predicting Market Moves?

View all articles
A.I. Advisor
published General Information

General Information

a developer of biologic drugs

Industry PharmaceuticalsOther

Industry
Biotechnology
Address
41 Seyon Street
Phone
+1 781 250-0111
Employees
2000
Web
https://www.repligen.com
Who owns Repligen? RGEN symbol Ownership - Tickeron.com